Apogee Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(3.4%),Peter Kolchinsky(3.4%)等
Apogee Therapeutics | SC 13G:超過5%持股股東披露文件-DRIEHAUS CAPITAL MANAGEMENT LLC(5.63%)
Apogee Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-Deep Track Capital, LP(2.22%),Deep Track Biotechnology Master Fund, Ltd.(2.22%)等
Apogee Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-FMR LLC(16.672%),Abigail P. Johnson(16.672%)
Apogee Therapeutics | 8-K:Apogee Therapeutics提供管道進展並公佈2024年第三季度財務業績
Apogee Therapeutics | 10-Q:2024財年三季報
Apogee Therapeutics | 4:持股變動聲明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股變動聲明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(6.6%)
Apogee Therapeutics | 144:擬議出售證券
Apogee Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)-AI Biotechnology LLC(4.87%),Access Industries Holdings LLC(4.87%)等
Apogee Therapeutics | 8-K:重大事件
Apogee Therapeutics | SC 13G:超過5%持股股東披露文件-BlackRock, Inc.(6.6%)
Apogee Therapeutics | 4:持股變動聲明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股變動聲明-高管 HENDERSON MICHAEL THOMAS
Apogee Therapeutics | SC 13G:超過5%持股股東披露文件-Wellington Management Group LLP(10.70%),Wellington Group Holdings LLP(10.70%)等
Apogee Therapeutics | 144:擬議出售證券
Apogee Therapeutics | 144:擬議出售證券
Apogee Therapeutics | 4:持股變動聲明-高管 Dambkowski Carl
Apogee Therapeutics | 4:持股變動聲明-高管 HENDERSON MICHAEL THOMAS
暫無數據
暫無數據